Role of Glucagon‐Like Peptide‐1 Receptor Agonists in Achieving Weight Loss and Improving Cardiovascular Outcomes in People With Overweight and Obesity

Host Laxmi Mehta interviews Dr. Erin Michos from Johns Hopkins University about her review article "Role of Glucagon‐Like Peptide‐1 Receptor Agonists in Achieving Weight Loss and Improving Cardiovascular Outcomes in People With Overweight and Obesity." Dr. Michos discusses how prescribing GLP-1 receptor agonists to treat obesity can help preventive cardiologists reduce their patients' overall cardiovascular risk, and how engaging in self-care can help clinicians achieve better outcomes for their patients.

For the full article: Click here